Prescott Group Capital Management L.L.C. boosted its holdings in shares of ATRenew Inc. (NYSE:RERE - Free Report) by 31.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,035,436 shares of the company's stock after purchasing an additional 724,415 shares during the period. ATRenew comprises approximately 0.5% of Prescott Group Capital Management L.L.C.'s investment portfolio, making the stock its 11th biggest holding. Prescott Group Capital Management L.L.C. owned approximately 1.24% of ATRenew worth $8,742,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. QRG Capital Management Inc. acquired a new stake in ATRenew during the fourth quarter valued at $48,000. SG Americas Securities LLC purchased a new stake in shares of ATRenew during the 4th quarter worth about $137,000. Quadrature Capital Ltd grew its position in shares of ATRenew by 67.8% during the 3rd quarter. Quadrature Capital Ltd now owns 70,729 shares of the company's stock valued at $197,000 after acquiring an additional 28,569 shares during the period. Harber Asset Management LLC grew its position in shares of ATRenew by 14.6% during the 3rd quarter. Harber Asset Management LLC now owns 1,094,617 shares of the company's stock valued at $3,043,000 after acquiring an additional 139,842 shares during the period. Finally, Centiva Capital LP increased its stake in shares of ATRenew by 342.2% in the 3rd quarter. Centiva Capital LP now owns 75,483 shares of the company's stock valued at $210,000 after purchasing an additional 58,413 shares in the last quarter. 19.29% of the stock is owned by institutional investors and hedge funds.
ATRenew Stock Up 9.3 %
Shares of ATRenew stock traded up $0.30 on Tuesday, reaching $3.48. The company's stock had a trading volume of 2,919,470 shares, compared to its average volume of 1,183,276. The company has a market capitalization of $847.94 million, a P/E ratio of -69.53, a PEG ratio of 0.41 and a beta of 0.08. The stock has a 50-day moving average price of $2.84 and a 200-day moving average price of $2.73. ATRenew Inc. has a 52-week low of $1.15 and a 52-week high of $3.70.
ATRenew (NYSE:RERE - Get Free Report) last posted its quarterly earnings data on Tuesday, March 11th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($0.02). ATRenew had a positive return on equity of 6.87% and a negative net margin of 0.53%. Sell-side analysts forecast that ATRenew Inc. will post 0.09 earnings per share for the current fiscal year.
About ATRenew
(
Free Report)
ATRenew Inc, through its subsidiaries, operates pre-owned consumer electronics transactions and services platform in the People's Republic of China. It primarily sells mobile phones, laptops, tablets, drones, digital cameras; and vintage bags, watches, liquor, gold, and various household goods through its online platforms and offline stores, as well as provides services to third-party merchants to sell the products through its platforms.
Featured Articles

Before you consider ATRenew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ATRenew wasn't on the list.
While ATRenew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.